CytoGen, Inc. is a holding company which engages in the researche and development of cancer treatment solutions. Its services include genetic testing, blood staining and circulating tumor cells analysis. The company was founded on March 18, 2010 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company